Venturi Wealth Management LLC Sells 1,578 Shares of MKS Inc. $MKSI

Posted by Brian Himes on Jun 29th, 2026

Venturi Wealth Management LLC lessened its holdings in MKS Inc. (NASDAQ:MKSI – Free Report) by 36.6% during the first quarter, according to its most recent disclosure with the SEC. The institutional investor owned 2,736 shares of the scientific and technical instruments company’s stock after selling 1,578 shares during the period. Venturi Wealth Management LLC’s holdings in MKS were worth $629,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its position in shares of MKS by 3.6% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 267,421 shares of the scientific and technical instruments company’s stock worth $21,434,000 after purchasing an additional 9,170 shares during the last quarter. EverSource Wealth Advisors LLC lifted its position in MKS by 63.4% during the second quarter. EverSource Wealth Advisors LLC now owns 838 shares of the scientific and technical instruments company’s stock valued at $83,000 after purchasing an additional 325 shares during the last quarter. First Trust Advisors LP lifted its position in MKS by 3,545.6% during the second quarter. First Trust Advisors LP now owns 141,267 shares of the scientific and technical instruments company’s stock valued at $14,036,000 after purchasing an additional 137,392 shares during the last quarter. Cerity Partners LLC purchased a new position in MKS in the 2nd quarter worth approximately $1,676,000. Finally, AXA S.A. increased its holdings in shares of MKS by 22.8% in the 2nd quarter. AXA S.A. now owns 29,253 shares of the scientific and technical instruments company’s stock worth $2,907,000 after buying an additional 5,430 shares during the last quarter. 99.79% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of analysts have recently issued reports on MKSI shares. The Goldman Sachs Group reaffirmed a “sell” rating and set a $265.00 price objective on shares of MKS in a report on Thursday, May 7th. Mizuho set a $400.00 price objective on MKS in a report on Wednesday, May 27th. Needham & Company LLC raised their price objective on MKS from $300.00 to $360.00 and gave the company a “buy” rating in a report on Thursday, May 7th. JPMorgan Chase & Co. boosted their target price on MKS from $305.00 to $365.00 and gave the stock an “overweight” rating in a research report on Friday, May 8th. Finally, Wall Street Zen lowered MKS from a “strong-buy” rating to a “buy” rating in a research note on Saturday, May 23rd. Two analysts have rated the stock with a Strong Buy rating, ten have given a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $343.77.

View Our Latest Analysis on MKSI

MKS Price Performance

Shares of MKSI stock opened at $388.61 on Monday. The company has a debt-to-equity ratio of 0.94, a quick ratio of 0.70 and a current ratio of 1.11. MKS Inc. has a fifty-two week low of $88.49 and a fifty-two week high of $421.58. The firm has a market cap of $26.25 billion, a P/E ratio of 81.30, a P/E/G ratio of 1.11 and a beta of 1.99. The business’s 50 day moving average price is $322.93 and its 200-day moving average price is $254.13.

MKS (NASDAQ:MKSI – Get Free Report) last announced its earnings results on Wednesday, May 6th. The scientific and technical instruments company reported $2.30 EPS for the quarter, beating analysts’ consensus estimates of $2.00 by $0.30. MKS had a return on equity of 21.49% and a net margin of 8.06%.The company had revenue of $1.08 billion during the quarter, compared to the consensus estimate of $1.05 billion. During the same quarter in the prior year, the company earned $1.71 earnings per share. The firm’s revenue for the quarter was up 15.2% on a year-over-year basis. MKS has set its Q2 2026 guidance at 2.600-3.200 EPS. On average, equities research analysts anticipate that MKS Inc. will post 11.73 earnings per share for the current year.

MKS Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, June 12th. Stockholders of record on Wednesday, June 3rd were given a $0.25 dividend. This represents a $1.00 annualized dividend and a dividend yield of 0.3%. The ex-dividend date of this dividend was Wednesday, June 3rd. MKS’s dividend payout ratio (DPR) is currently 20.92%.

Insider Transactions at MKS

In other news, Director Joseph B. Donahue sold 2,100 shares of MKS stock in a transaction dated Wednesday, May 27th. The shares were sold at an average price of $327.95, for a total transaction of $688,695.00. Following the sale, the director owned 10,033 shares of the company’s stock, valued at approximately $3,290,322.35. The trade was a 17.31% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP David Philip Henry sold 2,500 shares of the business’s stock in a transaction dated Tuesday, May 26th. The shares were sold at an average price of $330.50, for a total transaction of $826,250.00. Following the transaction, the executive vice president owned 16,341 shares in the company, valued at $5,400,700.50. This represents a 13.27% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders sold 53,949 shares of company stock worth $17,446,108. 0.57% of the stock is owned by corporate insiders.

MKS Profile

(Free Report)

MKS Instruments, Inc (NASDAQ: MKSI) designs, manufactures and markets technology solutions that enable advanced processes in a variety of high‐technology and industrial markets. The company’s core offerings include vacuum and gas delivery systems, pressure and flow measurement instruments, optical metrology tools, photonics subsystems and critical components for manufacturing processes. These products support the precise control and monitoring needs of semiconductor, industrial manufacturing, life and health sciences, and research applications.

The company’s product portfolio features mass flow controllers, pressure transducers, vacuum gauges, gas purity monitors, laser-based metrology systems and photonic devices such as lasers and detectors.